NCIA’s #IndustryEssentials webinar series is our premier digital educational platform featuring a variety of interactive programs allowing us to provide you timely, engaging and essential education when you need it most.

The NCIA Committee Insights series showcases content produced in partnership with one of our 15 member-led committees.

Members of NCIA’s Scientific Advisory Committee have convened a panel of leading clinical, regulatory and cannabis technology experts to lead a very timely discussion surrounding cannabis and COVID-19. This webinar will give an overview of the effects of COVID-19 on the body with a discussion on the research related to cannabis based treatments.

Learning Objectives:
• Learn about COVID-19 and how it infects the mammalian body’s organ systems.
• Discuss the endocannabinoid systems role in the immune response and how research supports its role in COVID-19.
• Outline implications of cannabinoid treatments based on available research including the most recent acidic cannabinoid study that has been all over the media.
• Identify areas of interest for future research.

Speakers:
Dr. Paloma Lehfeldt, MD, MA
Senior Director of Clinical Science and Partnerships
Goodness Growth Holdings

Lucy Postolov
Owner and President
Cannapy Health LLC / Postolova Acupuncture Group, Inc.

Bryant Godfrey
Partner
Foley Hoag

Jim Makoso
Director / CEO
Lucid Lab Group / Flowe Technology